Research from Tech in Asia, Tech in Asia

Tech in Asia

Tech in Asia (YC W15) is the largest English-language technology media company that focuses on Asia. From the latest news to the hottest trends and the boldest startups to the strongest titans, we cover everything tech in the region. Our goal is to build and serve Asia’s tech and startup community.

Research from Tech in Asia

News from Tech in Asia

Private Capital Markets

“The brain is a complex organ, and also the least understood,” <a href="https://www.linkedin.com/in/szepang/?originalSubdomain=sg" target="_blank" rel="noopener">Pang Sze Yunn</a>, co-founder and CEO of Singapore-based healthtech platform <a href="https://neurowyzr.com/" target="_blank" rel="noopener">Neurowyzr</a>, told Tech in Asia. According to Pang, early brain decline can take between 20 and 40 years before obvious conditions such as dementia, mental health diseases, or stroke occur.“By then, therapies have little impact,” she added. “Traditional brain tests are inefficient, expensive and inaccessible.”

“The brain is a complex organ, and also the least understood,” Pang Sze Yunn, co-founder and CEO of Singapore-based healthtech platform Neurowyzr, told Tech in Asia. According to Pang, early brain decline can take between 20 and 40 years before obvious conditions such as dementia, mental health diseases, or stroke occur.“By then, therapies have little impact,” she added. “Traditional brain tests are inefficient, expensive and inaccessible.”

Peak XV, Jungle Ventures Invest $2.1m in SG Brain Healthtech Firm